---
title: High Throughput Newborn Screening for Sickle Cell Disease - Application of
  Two-Tiered Testing with a qPCR-Based Primary screen
date: '2023-09-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37748509/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230926181447&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: In high-throughput NBS for SCD, qPCR is suitable to focus
  2^(nd)-tier analyses on samples containing HbS, while being unaffected by factors
  such as prematurity or transfusions. The substantial reduction of samples numbers
  positively impacts resource conservation, sustainability, and cost-effectiveness.
  No false negative cases came to ...'
disable_comments: true
---
CONCLUSION: In high-throughput NBS for SCD, qPCR is suitable to focus 2^(nd)-tier analyses on samples containing HbS, while being unaffected by factors such as prematurity or transfusions. The substantial reduction of samples numbers positively impacts resource conservation, sustainability, and cost-effectiveness. No false negative cases came to ...